Targeting of a natural killer cell receptor family by a viral immunoevasin
Richard Berry, Natasha Ng, Philippa M Saunders, Julian P Vivian, Jie Lin, Felix A Deuss, Alexandra J Corbett, Catherine A Forbes, Jacqueline M Widjaja, Lucy C Sullivan, Adrian D McAlister, Matthew A Perugini, Melissa J Call, Anthony A Scalzo, Mariapia A Degli-Esposti, Jerome D Coudert, Travis Beddoe, Andrew G Brooks, Jamie Rossjohn
Nature Immunology | NATURE PUBLISHING GROUP | Published : 2013
We thank the staff of the crystallization facility of Monash University for assistance; A. Shahine, R. Koh, M. Peverelli and I. Larma for technical assistance; S. Lemieux (Institut Armand-Frappier) for the 4LO3311 hybridoma; and W. Yokoyama (Washington University) for BWZ HD12 and BWZ DAP12 cells and the 3D10 hybridoma. This research was undertaken on the MX2 beamline at the Australian Synchrotron, Victoria, Australia. Supported by the National Health and Medical Research Council of Australia (M.J.C., R. B., L. C. S., J.D.C. and J.R.), Australian Research Council (M. A. P., M.J.C. and J.P.V.) and Pfizer Australia (T.B.).